CapitaLand Ascendas REIT Officially Launches S$1.4 Billion Geneo Project to Revitalise Singapore Science Park

NewTimeSpace News: On May 22, 2026, CapitaLand Ascendas REIT inaugurated Geneo life science and innovation centre in Singapore.

Jointly owned by CapitaLand Development and CapitaLand Ascendas REIT, the development boasts a total gross floor area of around 180,600 square metres. About 80,000 square metres are purpose-built facilities for biomedical research, flexible laboratories and innovative office premises.

The project has secured tenancy from multiple global leading enterprises, namely A*STAR, Barry Callebaut, Chugai Pharmaceutical, Henkel and NSG Bio. These businesses span biotechnology, advanced manufacturing, food innovation and pharmaceutical research and development sectors.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.